Given that semaglutide works to reduce a patients blood sugar (glycaemia), the authors concluded semaglutide-related NAION may be a consequence of glycaemia reduction and not an off-target effect. It was recommended that a base-line eye examination be conducted prior to the start of semaglutide to identity patients who may be at risk of developing NAION
Recovery: You will sit in a refreshment area for 15 minutes to have a snack and a drink, ensuring you feel fine before leaving
However, the translation to clinical efficacy in human osteoarthritis remains ambiguous, as weight loss appears to play a substantial role in pain alleviation [21, 22]
Continuously injecting into the same small area can lead to several issues: Skin Irritation: Redness, soreness, or itching at the injection site
After 36 weeks of open-label tirzepatide treatment producing an average 20.9 percent weight loss, participants were randomized to either continue tirzepatide or switch to placebo